Vascugen Inc. news

The Indiana University Philanthropic Venture Fund, which provides capital to faculty, students, alumni and staff at all IU campuses to help them further develop their research and innovations into startup companies, has invested in Vascuqen Inc., a regenerative medicine company.

Vascugen is focused on finding therapies to repair human tissue damaged by reduced blood flow due to disease or injury. The company has received additional investment from other Indiana-based investors, inc

Vascuqen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease or injury.

The worldwide, exclusive licenses include patent rights to core intellectual property developed by Dr. Mervin C. Yoder. a Vascugen founder and IU